Lingfeng Meng
Impact in
- Urology top 5%
- Urinary Bladder and Prostate Research
-
- Cancer-related molecular mechanisms research
- Cancer, Lipids, and Metabolism
Papers in
- Urology 15
- Urinary Bladder and Prostate Research 15
-
- Ferroptosis and cancer prognosis 10
- Prostate Cancer Diagnosis and Treatment 3
- Renal cell carcinoma treatment 2
- Co-authors
- Yaoguang Zhang (23 shared papers)Jianye Wang (21 shared papers)Xiaodong Liu (10 shared papers)Zijian Tian (18 shared papers)Tongxiang Diao (11 shared papers)Maolin Hu (9 shared papers)Miao Wang (9 shared papers)Zhengtong Lv (4 shared papers)
- Journals
- International Journal of Surgery (3 papers)Frontiers in Molecular Biosciences (2 papers)Frontiers in Medicine (2 papers)BMC Cancer (2 papers)Frontiers in Oncology (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Lingfeng Meng
40 papers receiving 307 citations
Peers
Comparison fields: 5 of 38
- Urology 76
- Cancer Research 55
- Pulmonary and Respiratory Medicine 81
- Rheumatology 37
- Surgery 66
Countries citing papers authored by Lingfeng Meng
This map shows the geographic impact of Lingfeng Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Meng more than expected).
Fields of papers citing papers by Lingfeng Meng
This network shows the impact of papers produced by Lingfeng Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Meng. The network helps show where Lingfeng Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingfeng Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 39 | |
| 2 | 2021 | 37 | |
| 3 | 2021 | 15 | |
| 4 | 2021 | 14 | |
| 5 | Effect of MUC16 mutations on tumor mutation burden and its potential prognostic significance for cutaneous melanoma. | 2022 | 13 |
| 6 | 2020 | 12 | |
| 7 | 2020 | 12 | |
| 8 | 2021 | 12 | |
| 9 | TNFSF13B and PPARGC1A expression is associated with tumor-infiltrating immune cell abundance and prognosis in clear cell renal cell carcinoma. | 2021 | 11 |
| 10 | 2020 | 11 | |
| 11 | 2020 | 10 | |
| 12 | 2022 | 10 | |
| 13 | Identification and validation of an immune-related gene-based prognostic index for bladder cancer. | 2020 | 10 |
| 14 | 2020 | 10 | |
| 15 | 2022 | 9 | |
| 16 | 2021 | 8 | |
| 17 | 2021 | 7 | |
| 18 | 2020 | 7 | |
| 19 | 2022 | 6 | |
| 20 | 2020 | 6 |
About Lingfeng Meng
Lingfeng Meng is a scholar working on Urology, Pulmonary and Respiratory Medicine, Surgery, Molecular Biology and Rheumatology, having authored 41 papers that have together received 309 indexed citations. Recurring topics across this work include Urinary Bladder and Prostate Research (15 papers), Ferroptosis and cancer prognosis (10 papers), Bladder and Urothelial Cancer Treatments (9 papers), Pelvic floor disorders treatments (7 papers), Epigenetics and DNA Methylation (6 papers), Prostate Cancer Diagnosis and Treatment (3 papers), RNA modifications and cancer (3 papers) and Renal cell carcinoma treatment (2 papers). The work is most often cited by research in Urology (76 citations), Cancer Research (55 citations), Pulmonary and Respiratory Medicine (81 citations), Rheumatology (37 citations) and Surgery (66 citations). Lingfeng Meng has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yaoguang Zhang, Jianye Wang, Xiaodong Liu, Zijian Tian, Tongxiang Diao, Maolin Hu, Miao Wang, Zhengtong Lv, Jingchao Liu and Jiawen Wang. Their work appears in journals such as International Journal of Surgery, Frontiers in Molecular Biosciences, Frontiers in Medicine, BMC Cancer and Frontiers in Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.